Please Wait...

Books and Book Sections

Books and Book Sections

2014

Miller CG, Krasnow J, Schwartz LH. Medical Imaging in Clinical Trials. Published by Springer-Verlag London Ltd. 2014.

Hide All Authored Chapters

  • Medical Imaging Modalities
    • H Ahmad, HJ Yu, CG Miller
  • The Metrics and New Imaging Marker Qualification in Medical Imaging Modalities
    • CG Miller
  • Radiation Risks and Dosimetry Assessment
    • D Pearson
  • Imaging Review Charters and Operational Considerations
    • AM Perrone, JA Villetard
  • Defining the Radiological Blinded Read and Adjudication
    • CG Miller
  • Medical Imaging in Drug Development
    • J Krasnow
  • Evaluating and Working with an Imaging Core Laboratory
    • ES Forsthoffer, J Krasnow
  • Monitoring Responses to Therapy in Oncology
    • B Zhao, LH Schwartz
  • Cardiac Imaging in Clinical Trials
    • GP Heyrich, J Krasnow
  • Neuroimaging in Clinical Trials
    • SN Niogi, AJ Tsiouris
  • Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials
    • CG Miller, HJ Yu, Cv Kuijk
  • Body Composition
    • JA Shepherd
  • Optical Coherence Tomography as a Biomarker in Clinical Trials for Ophthalmology and Neurology
    • RC Sergott
  • Nuclear Medicine: An Overview of Imaging Techniques, Clinical Applications and Trials
    • A Mehndiratta, P Anandaraj
  • Contrast Agents in Radiology
    • Hv Tengg-Kobligk, A Mehndiratta
  • Pharmaceutical Industry Perspective Regarding Imaging Techniques
    • J Krasnow

2008

Reid D, Miller CG. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Published by Springer-Verlag London Ltd. 2008.

Hide All Authored Chapters

  • Introduction
    • DM Reid
  • Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis
    • S Dubey, AO Adebajo
  • Development of Biological Therapies for Inflammatory Arthritis
    • N Basu
  • Study Design and End Points for Rheumatoid Arthritis Trials
    • P Geusens, CG Miller
  • Study Design and End Points in Ankylosing Spondylitis Clinical Trials
    • Dvd Heijde
  • Trial Design and Outcomes in Osteoarthritis
    • N Arden
  • Ethical Considerations
    • D Pearson
  • Organization of the Clinical Trial by the Sponsor
    • CG Miller
  • Organization of the Trial attheInvestigator Site
    • J Shotton, DM Reid
  • Role of the Imaging Core Laboratory in Rheumatoid Arthritis and Osteoarthritis Clinical Trials
    • MD Endres, AM Baratelle
  • Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations
    • MR Ehlers, ET Leary
  • Data Analysis and Presentation: Writing a Paper for Publication
    • D Pearson
  • Radiographic Imaging End Points in Rheumatoid Arthritis Trials
    • AM Baratelle, Dvd Heijde
  • Radiography in Clinical Trials Investigating Osteoarthritis
    • Cv Kuijk
  • Use of Quantitative Magnetic Resonance Imaging in the Cross-Sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients
    • JP Raynauld
  • Biochemical Markers as Surrogate End Points of Joint Disease
    • LS Lohmander, DR Eyre
  • Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis
    • SH Ralston
  • Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
    • YB Vergel, D Torgerson

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @lauren_chazal: OA is highly prevalent worldwide! Let's work together globally to fight OA... #orasi2017 @bioclinica https://t.co/sAofL…
bioclinica (2 days ago)
Awesome #TYCTWD in our Audubon office yesterday! Great grp of kids.Thanks all for making it a big hit & a day to r… https://t.co/gLZilvN4Wy
bioclinica (2 days ago)
[Fun Friday] When It Comes to Success, Age Really Is Just a Number Via NYT https://t.co/u82mvoYxhg
bioclinica (2 days ago)
RT @eClinical_Jen: Ron Fitzmartin of FDA states "The Reason why the FDA supports standards is to get medical products approved faster" 👍#C…
bioclinica (3 days ago)
RT @eClinical_Jen: Donate your health data to research! Check out the S4S project mentioned by @iamnotthelotus at #CDISCEurope #pharma http…
bioclinica (3 days ago)
RT @lauren_chazal: #oarsi2017 what IS the future of OA? @bioclinica https://t.co/Q9MhW8F50g
bioclinica (3 days ago)

Latest Blogs: